Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review

Details 詳細情報について

• CRID

  1363388845176196992

• DOI

  10.1016/j.mce.2011.07.002

• ISSN

  03037207

• Web Site

  https://api.elsevier.com/content/article/PII:S0303720711003789?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0303720711003789?httpAccept=text/plain

• Data Source

  • Crossref